Morgan Stanley posted its quarterly diluted earnings of $1.47 per share, missing the $1.52 a share expected by analysts polled by FactSet. Revenues of $12.99 billion for the quarter ended September, vs. analysts' expectations of $13.29 billion (based on FactSet poll) . Revenues were $14.75 billion a year ago.
The financial firm’s net interest income climbed +49% year-over-year to $2 billion, while investment banking revenue plunged -55% to $1.277 billion.
Revenue from Equity trading slipped -14% to $2.46 billion, while fixed-income trading revenue was up +33% to $2.18 billion.
"Firm performance was resilient and balanced in an uncertain and difficult environment, delivering a 15% return on tangible common equity," CEO James Gorman mentioned in a statement. "While Investment Banking and Investment Management were impacted by the market environment, Fixed Income and Equity navigated challenging markets well."
MS saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on November 14, 2025. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 40 instances where the indicator turned negative. In of the 40 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .
The 10-day RSI Indicator for MS moved out of overbought territory on November 13, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 47 similar instances where the indicator moved out of overbought territory. In of the 47 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Momentum Indicator moved below the 0 level on November 14, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on MS as a result. In of 70 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
MS moved below its 50-day moving average on November 20, 2025 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MS advanced for three days, in of 354 cases, the price rose further within the following month. The odds of a continued upward trend are .
MS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In of 330 cases where MS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 78, placing this stock better than average.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating outstanding price growth. MS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.517) is normal, around the industry mean (23.918). P/E Ratio (16.277) is within average values for comparable stocks, (70.814). Projected Growth (PEG Ratio) (1.281) is also within normal values, averaging (1.687). Dividend Yield (0.024) settles around the average of (0.035) among similar stocks. P/S Ratio (3.946) is also within normal values, averaging (1549513.500).
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a provider of diversified financial services including brokerage, investment management and venture capital services
Industry InvestmentBanksBrokers